Cure8 news brief
Why This Matters
Stopping Crohn's medications can cause flares and serious complications, and restarting treatment may be slower or less effective. Adherence and financial or practical support can help prevent these harms.
Who Should Pay Attention
Adults with Crohn's disease, patients on biologics or immunomodulators, caregivers, and IBD clinicians
Study Snapshot
What To Know
This Everyday Health piece summarizes expert opinion and published studies warning that stopping prescribed Crohn's treatments can lead to symptom relapse (diarrhea, abdominal pain, bleeding) and complications such as abscesses, fistulas, strictures, bowel perforation, toxic megacolon, or the need for surgery.
It cites a small study and reviews suggesting relapse after stopping biologics and notes risks from developing antibodies or hypersensitivity when restarting therapy. The article also emphasizes medication adherence strategies (support groups, contacting providers) and points readers to financial resources and assistance programs.
Keep In Mind
The article is a patient-education summary referencing published studies and guidelines; it does not present new clinical trial results. Individual risks depend on disease history and the specific medication.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.